These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10868533)

  • 1. Faecal occult blood test screening for colorectal cancer--what are we waiting for?
    Stanley AJ; St John DJ
    Aust N Z J Med; 1999 Aug; 29(4):545-51. PubMed ID: 10868533
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer: too early to be dogmatic.
    Solomon MJ
    Med J Aust; 1996 Jul; 165(2):68-9. PubMed ID: 8692061
    [No Abstract]   [Full Text] [Related]  

  • 4. Fecal occult blood testing for colorectal cancer. Can we afford not to do this?
    Bond JH
    Gastroenterol Clin North Am; 1997 Mar; 26(1):57-70. PubMed ID: 9119440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer.
    Timins JK
    N J Med; 1997 Aug; 94(8):37-41. PubMed ID: 9265830
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial.
    Whynes DK
    Crit Rev Oncol Hematol; 1999 Nov; 32(2):155-65. PubMed ID: 10612015
    [No Abstract]   [Full Text] [Related]  

  • 7. Offering patients colorectal cancer screening.
    Church TR
    J Natl Cancer Inst; 2005 Mar; 97(5):328-9. PubMed ID: 15741562
    [No Abstract]   [Full Text] [Related]  

  • 8. Colorectal cancer screening in asymptomatic populations.
    Hart AR; Wicks AC; Mayberry JF
    Gut; 1995 Apr; 36(4):590-8. PubMed ID: 7737570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summaries for patients. Screening for colorectal cancer: recommendations from the United States Preventive Services Task Force.
    Ann Intern Med; 2002 Jul; 137(2):I38. PubMed ID: 12118986
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening and surveillance for colorectal cancer.
    Schnoll-Sussman F; Markowitz AJ; Winawer SJ
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):10-21. PubMed ID: 11049028
    [No Abstract]   [Full Text] [Related]  

  • 11. What's new in colorectal cancer screening?
    Frommer DJ
    J Gastroenterol Hepatol; 1998 May; 13(5):528-33. PubMed ID: 9641653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is routine screening for colorectal cancer justifiable? These gastroenterologists say YES!
    Early DS; Marshall JB
    Postgrad Med; 1997 Jul; 102(1):48, 50-52. PubMed ID: 9224479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of costs and effects of screening for colorectal cancer in the United States.
    Byers T; Gorsky R
    Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Colorectal cancer screening is profitable].
    Pikkarainen P
    Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
    [No Abstract]   [Full Text] [Related]  

  • 15. [National colorectal carcinoma screening program deserves further study; a report from the Dutch Health Council].
    van Veen WA
    Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1655-7. PubMed ID: 11552370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Colorectal cancer in Germany. Means for prevention and early detection: implications for laiety and physicians].
    Eickhoff A; Maar C; Birkner B; Riemann JF
    Internist (Berl); 2003 Mar; 44(3):278, 281-6. PubMed ID: 12731414
    [No Abstract]   [Full Text] [Related]  

  • 18. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
    Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
    Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.